M. Giorgio

Diagnostic and Prognostic Role of α-Fetoprotein in Hepatocellular Carcinoma: Both or Neither?

M. Zoli, F. Farinati, F. Trevisani, 2006, The American Journal of Gastroenterology.

A reappraisal of the Barcelona Clinic Liver Cancer model: natural history of untreated ‘intermediate stage’ hepatocellular carcinoma

F. Farinati, F. Trevisani, D. Marino, 2004, Journal of internal medicine.

Megestrol treatment in patients with hepatocellular carcinoma

F. Farinati, S. Gianni, S. Fiorentini, 2001, British Journal of Cancer.

Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

V. Mazzaferro, J. Bruix, P. Lampertico, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Tumour staging, morphology and p53 overexpression concur in predicting survival in hepatocellular carcinoma

G. Altavilla, F. Farinati, S. Fagiuoli, 2005, Journal of Internal Medicine.

Small HCCs Identified by Screening

B. Carr, S. Fagiuoli, M. Giorgio, 2011, Digestive Diseases and Sciences.